PUBLIC CITIZEN for PUBLIC CITIZEN
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Banking BAN
Proposal for dual class stock reform, National Economic Council meeting regarding executive compensation reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| BARTLETT NAYLOR | — |
Budget/Appropriations BUD
Eliminate the c4 rider
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY PETERSON CASSIN | — |
Consumer Issues/Safety/Products CSP
Product safety priorities, Portable adult bed rails, Sunshine in Product Safety Act, Regulatory reform, HR 6107-Stop Corporate Capture Act, Forthcoming privacy bill, Kids Online Safety and Privacy Act, COPPA 2.0, FTC Act section 13 B authority, HR 3816/S 2992-American Innovation and Choice online act, HR 3825-Ending Platform Monopolies Act, HR 3826-Platform competition & Opportunity Act of 2021, HR 5017/S 2710-Open App Markets Act, Regulatory modernization at OIRA
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| MATT KENT | — |
| AMIT NARANG | — |
| MARTHA PEREZ-PEDEMONTI New | — |
| EMILY PETERSON CASSIN | — |
| ELIZABETH SKERRY New | — |
Government Issues GOV
S 564/HR 1579, S 3612/HR 6694, S 3494, HR336, S 3631-Congressional Insider trading restrictions, National Defense Authorization Act of 2023 (Eliminating the LDA exemption), Protect our Democracy Act-S 2921, S 241-Article one Act, No tax deductions for workplace harasser buyouts act, HR 6283-Get Foreign Money out of US Elections, FOIA reform,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| CRAIG HOLMAN | — |
Law Enforcement/Crime/Criminal Justice LAW
FAIR act,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
Labor Issues/Antitrust/Workplace LBR
Whistleblower rights and protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULEY FULCHER | — |
Pharmacy PHA
HR 4502-(fy2022 Consolidated Appropriations Act), Covid-19 Vaccine manufacturing, delivery and access and related funding, S 3799 Prevent Pandemics Act (R&D Access conditions, Public MCM manufacturing, Discounted drugs for clinical Trials Act, Pharmaceutical Research and Transparency Act, Generic Substitution Non-Interference Act, drug pricing, FDA-PTO coordination, orange book reform, NDAA licensing access and drug pricing conditions, S 3700-Affordable Insulin Now Act, Drug pricing patent licensing executive Action, Compulsory licensing to lower drug prices, HR 4521-COMPETES Act mandatory drug recall authority provision, HR 7667/ S 4348-User fee legislation, advisory committee and recall provisions, NIH Director position,
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KNIEVEL | — |
Taxation/Internal Revenue Code TAX
Eliminate the c4 rider, Financial Transaction tax, International tax reform, tax filing simplification, IRS enforcement-Non Profits,
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN ELAINE HARLEY | — |
| EMILY PETERSON CASSIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.